{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These complications have included clinical deterioration and intracranial vascular thrombosis in patients with SAH , arteriolar and capillary fibrin thrombi in patients with fibrinolytic syndromes treated with EACA , or other thromboembolic phenomena .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| SAH (Subarachnoid Hemorrhage) |\n| Fibrinolytic syndromes |\n| Intracranial vascular thrombosis |\n| Arteriolar and capillary fibrin thrombi |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| SAH (Subarachnoid Hemorrhage) |\n| Intracranial vascular thrombosis |\n| Arteriolar and capillary fibrin thrombi |\n\nNote: \"Fibrinolytic syndromes\" is not a specific disease, but rather a condition or syndrome. However, since the paragraph mentions \"patients with fibrinolytic syndromes,\" it can be inferred that the context refers to certain diseases or conditions that cause fibrinolytic syndromes. Therefore, it is included in the list for completeness, but it is not a precise disease entity."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These complications have included clinical deterioration and intracranial vascular thrombosis in patients with SAH , arteriolar and capillary fibrin thrombi in patients with fibrinolytic syndromes treated with EACA , or other thromboembolic phenomena .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| SAH (Subarachnoid Hemorrhage) |\n| EACA (Epsilon-Aminocaproic Acid) |\n| Fibrin |\n| Thrombosis |\n| Arteriolar and capillary |\n| Intracranial |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| SAH (Subarachnoid Hemorrhage) |\n| Epsilon-Aminocaproic Acid (EACA) |\n| Fibrin |\n| Thrombosis |"}
  ]
}